Evaluation of topical immunotherapy with squaric acid dibutylester, systemic interferon alpha and the combination of both in the treatment of chronic severe alopecia areata
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Dermatological Treatment
- Vol. 6 (2), 95-98
- https://doi.org/10.3109/09546639509097159
Abstract
A total of 30 patients with severe recalcitrant alopecia areata were randomly assigned to one of three groups. One group was treated with topical immunotherapy (TI) with squaric acid dibutylester at weekly intervals, for a maximum of 32 weeks, the second group was treated with lymphoblastoid interferon (IFN) alpha given by the intramuscular route for a 3-month period, and the third group received a combination of both treatments. After discontinuation of therapy the patients were followed-up at 4-week intervals for a 6-month period. At the end of this period, clinical responses were assessed according to the following four-point scale: 3 = full and stable recovery with a 6-month relapse-free period; 2 = full recovery with relapse occurring within 6 months; 1 = partial recovery; 0 = no response or disease progression. Combination (TI + IFN) therapy patients had significantly (P = 0.02) higher cure rates. In this group, scores of 3 and 2 were given to three and two patients, respectively. By contrast, in both monotherapy groups no score 3 was assigned, and only two patients were assessed as score 2. This study provides some support for the hypothesis that the association of TI and systemic IFNs are more effective than either treatment alone. The possibility of a synergistic action is discussed.Keywords
This publication has 20 references indexed in Scilit:
- Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluationJournal of the American Academy of Dermatology, 1993
- Interferons in Multiple SclerosisDrugs, 1992
- Topical Immunotherapy for Alopecia areata: Re-Evaluation of 139 Cases after an Additional Follow-Up Period of 19 MonthsDermatology, 1992
- Summary of Alopecia Areata Research Workshop and Future Research DirectionsJournal of Investigative Dermatology, 1991
- Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenoneJournal of the American Academy of Dermatology, 1991
- Alopecia AreataInternational Journal of Dermatology, 1990
- Oral cyclosporine for the treatment of alopecia areata: A clinical and immunohistochemical analysisJournal of the American Academy of Dermatology, 1990
- Abnormal Expression of Class I and Class II Major Histocompatibility Antigens in Alopecia Areata: Modulation by Topical Immunotherapy*Journal of Investigative Dermatology, 1987
- Alopecia areata incognita: A HypothesisDermatology, 1987
- Clinical and immunologic response to Isoprinosine in alopecia areata and alopecia universalis: Association with autoantibodiesJournal of the American Academy of Dermatology, 1985